Anaptysbio Stock Investor Sentiment
| ANAB Stock | USD 24.38 0.58 2.32% |
About 76 percent of AnaptysBio's investors are selling. The analysis of the overall investor sentiment regarding AnaptysBio suggests that quite a large number of traders are terrified. The current market sentiment, together with AnaptysBio's historical and current headlines, can help investors time the market. In addition, many technical investors use AnaptysBio stock news signals to limit their universe of possible portfolio assets.
AnaptysBio |
AnaptysBio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards AnaptysBio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about AnaptysBio that are available to investors today. That information is available publicly through AnaptysBio media outlets and privately through word of mouth or via AnaptysBio internal channels. However, regardless of the origin, that massive amount of AnaptysBio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AnaptysBio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AnaptysBio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AnaptysBio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AnaptysBio alpha.
AnaptysBio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 1300 shares by Orwin John A of AnaptysBio subject to Rule 16b-3 | 09/13/2024 |
2 | Disposition of 10000 shares by Dennis Mulroy of AnaptysBio at 40.13 subject to Rule 16b-3 | 09/16/2024 |
3 | Disposition of 3780 shares by Eric Loumeau of AnaptysBio at 38.4103 subject to Rule 16b-3 | 09/17/2024 |
4 | AnaptysBio chief medical officer sells shares worth over 58,000 | 09/24/2024 |
5 | Disposition of 5000 shares by Eric Loumeau of AnaptysBio at 14.02 subject to Rule 16b-3 | 10/14/2024 |
6 | AnaptysBio stock falls as Lilly updates pipeline | 10/30/2024 |
7 | Anaptys Announces Participation in November and December Investor Conferences | 11/05/2024 |
8 | AnaptysBio stock target cut on increased expenses | 11/06/2024 |
9 | Guggenheim sustains buy on ANAB shares with strong trial prospects | 11/07/2024 |
10 | Down -32.84 percent in 4 Weeks, Heres Why You Should You Buy the Dip in AnaptysBio | 11/08/2024 |
11 | EcoR1 Capital, LLC Increases Stake in Aligos Therapeutics Inc | 11/15/2024 |
12 | ANAB to Host Webinar on Department of Defense Cyber Workforce Qualification Program and ANAB Accreditation under DoD Directive 8140 | 11/22/2024 |
13 | BTIG cuts AnaptysBio shares to neutral on high-risk trial setup | 12/02/2024 |
Complementary Tools for AnaptysBio Stock analysis
When running AnaptysBio's price analysis, check to measure AnaptysBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnaptysBio is operating at the current time. Most of AnaptysBio's value examination focuses on studying past and present price action to predict the probability of AnaptysBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnaptysBio's price. Additionally, you may evaluate how the addition of AnaptysBio to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |